On May 30, 2025, Gufic Biosciences Ltd announced plans for additional investments of up to ₹1 crore each in its subsidiaries Veira Life FZE and Gufic Ireland Limited. This expansion follows earlier board decisions regarding financial results and dividends for FY 2024-25.